These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 19848555

  • 1. Comparative effects of continuous combined hormone therapy and tibolone on body composition in postmenopausal women.
    Ziaei S, Moaya M, Faghihzadeh S.
    Climacteric; 2010 Jun; 13(3):249-53. PubMed ID: 19848555
    [Abstract] [Full Text] [Related]

  • 2. Comparative effects of conventional hormone replacement therapy and tibolone on climacteric symptoms and sexual dysfunction in postmenopausal women.
    Ziaei S, Moghasemi M, Faghihzadeh S.
    Climacteric; 2010 Apr; 13(2):147-56. PubMed ID: 19731119
    [Abstract] [Full Text] [Related]

  • 3. Effects of hormone therapy and tibolone on body composition and serum leptin levels in postmenopausal women.
    Dedeoğlu EN, Erenus M, Yörük P.
    Fertil Steril; 2009 Feb; 91(2):425-31. PubMed ID: 18249383
    [Abstract] [Full Text] [Related]

  • 4. A randomized, open-label study of conjugated equine estrogens plus medroxyprogesterone acetate versus tibolone: effects on symptom control, bleeding pattern, lipid profile and tolerability.
    Baracat EC, Barbosa IC, Giordano MG, Haidar MA, Marinho RM, Menegocci JC, Morais KM, Tomaz G, Wehba S.
    Climacteric; 2002 Mar; 5(1):60-9. PubMed ID: 11974560
    [Abstract] [Full Text] [Related]

  • 5. Effect of hormone replacement therapy and tibolone on serum leptin levels in postmenopausal women.
    Lambrinoudaki IV, Christodoulakos GE, Panoulis CP, Rizos DA, Dendrinos SG, Liakakos T, Augoulea AD, Creatsas GC.
    Maturitas; 2004 Jun 15; 48(2):107-13. PubMed ID: 15172084
    [Abstract] [Full Text] [Related]

  • 6. Conjugated estrogen/progestagen versus tibolone hormone replacement therapy in postmenopausal women: Effects on carbohydrate metabolism and serum sex hormone-binding globulin.
    Odmark IS, Carlström K, Jonsson B, Jonasson AF.
    Maturitas; 2006 Jan 10; 53(1):89-96. PubMed ID: 15964160
    [Abstract] [Full Text] [Related]

  • 7. Effect on sexual life--a comparison between tibolone and continuous combined conjugated equine estrogens and medroxyprogesterone acetate.
    Uygur D, Yeşildaglar N, Erkaya S.
    Gynecol Endocrinol; 2005 Apr 10; 20(4):209-12. PubMed ID: 16019363
    [Abstract] [Full Text] [Related]

  • 8. The effect of continuous combined conjugated equine estrogen plus medroxyprogesterone acetate and tibolone on cardiovascular metabolic risk factors.
    Skouby SO, Sidelmann JJ, Nilas L, Gram J, Jespersen J.
    Climacteric; 2008 Apr 10; 11(6):489-97. PubMed ID: 18991076
    [Abstract] [Full Text] [Related]

  • 9. Cognitive function variations in postmenopausal women treated with continuous, combined HRT or tibolone. A comparison.
    Pan HA, Wang ST, Pai MC, Chen CH, Wu MH, Huang KE.
    J Reprod Med; 2003 May 10; 48(5):375-80. PubMed ID: 12815913
    [Abstract] [Full Text] [Related]

  • 10. Effects of tibolone and continuous combined hormone therapy on mammographic breast density and breast histochemical markers in postmenopausal women.
    Valdivia I, Campodónico I, Tapia A, Capetillo M, Espinoza A, Lavín P.
    Fertil Steril; 2004 Mar 10; 81(3):617-23. PubMed ID: 15037411
    [Abstract] [Full Text] [Related]

  • 11. Effects of low-dose continuous combined conjugated estrogens and medroxyprogesterone acetate on menopausal symptoms, body weight, bone density, and metabolism in postmenopausal women.
    Gambacciani M, Ciaponi M, Cappagli B, Genazzani AR.
    Am J Obstet Gynecol; 2001 Nov 10; 185(5):1180-5. PubMed ID: 11717654
    [Abstract] [Full Text] [Related]

  • 12. Serum androgen levels and insulin resistance in postmenopausal women: association with hormone therapy, tibolone and raloxifene.
    Christodoulakos G, Lambrinoudaki I, Panoulis C, Sioulas V, Rizos D, Caramalis G, Botsis D, Creatsas G.
    Maturitas; 2005 Apr 11; 50(4):321-30. PubMed ID: 15780533
    [Abstract] [Full Text] [Related]

  • 13. Effects of postmenopausal hormone replacement therapy on body fat composition.
    Yüksel H, Odabasi AR, Demircan S, Köseoğlu K, Kizilkaya K, Onur E.
    Gynecol Endocrinol; 2007 Feb 11; 23(2):99-104. PubMed ID: 17454160
    [Abstract] [Full Text] [Related]

  • 14. The effect of tibolone and continuous combined conjugated equine oestrogens plus medroxyprogesterone acetate on progression of carotid intima-media thickness: the Osteoporosis Prevention and Arterial effects of tiboLone (OPAL) study.
    Bots ML, Evans GW, Riley W, McBride KH, Paskett ED, Helmond FA, Grobbee DE, OPAL Investigators.
    Eur Heart J; 2006 Mar 11; 27(6):746-55. PubMed ID: 16415304
    [Abstract] [Full Text] [Related]

  • 15. Serum leptin levels and body composition in postmenopausal women treated with tibolone and raloxifene.
    Tommaselli GA, Di Carlo C, Di Spiezio Sardo A, Bifulco G, Cirillo D, Guida M, Capasso R, Nappi C.
    Menopause; 2006 Mar 11; 13(4):660-8. PubMed ID: 16837888
    [Abstract] [Full Text] [Related]

  • 16. Flow resistance in carotid and middle cerebral arteries in postmenopausal women: a comparative study of tibolone and continuous combined hormone replacement therapy.
    Pan HA, Wang ST, Chen CH, Pai MC, Wu MH, Huang KE.
    Climacteric; 2002 Sep 11; 5(3):259-65. PubMed ID: 12419084
    [Abstract] [Full Text] [Related]

  • 17. The differential effect of estrogen, estrogen-progestin and tibolone on coagulation inhibitors in postmenopausal women.
    Keramaris NC, Christodoulakos GE, Lambrinoudaki IV, Dalamanga A, Alexandrou AP, Bramis J, Bastounis E, Creatsas GC.
    Climacteric; 2007 Oct 11; 10(5):400-7. PubMed ID: 17852143
    [Abstract] [Full Text] [Related]

  • 18. A comparative study of the effect of continuous combined conjugated equine estrogen plus medroxyprogesterone acetate and tibolone on blood coagulability.
    Skouby SO, Sidelmann JJ, Nilas L, Jespersen J.
    Hum Reprod; 2007 Apr 11; 22(4):1186-91. PubMed ID: 17204528
    [Abstract] [Full Text] [Related]

  • 19. Economic impact of Tibolone compared with Continuous-Combined Hormone Replacement Therapy in the management of climacteric symptoms in postmenopausal women.
    Diaby V, Perreault S, Lachaine J.
    Maturitas; 2007 Oct 20; 58(2):138-49. PubMed ID: 17870259
    [Abstract] [Full Text] [Related]

  • 20. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels.
    Pluchino N, Genazzani AD, Bernardi F, Casarosa E, Pieri M, Palumbo M, Picciarelli G, Gabbanini M, Luisi M, Genazzani AR.
    Gynecol Endocrinol; 2005 Mar 20; 20(3):144-9. PubMed ID: 16019353
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.